0000899243-18-029073.txt : 20181115 0000899243-18-029073.hdr.sgml : 20181115 20181115215304 ACCESSION NUMBER: 0000899243-18-029073 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20181113 FILED AS OF DATE: 20181115 DATE AS OF CHANGE: 20181115 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: NOVOSEL THOMAS C CENTRAL INDEX KEY: 0001229401 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34723 FILM NUMBER: 181188558 MAIL ADDRESS: STREET 1: AMERICOLD REALTY TRUST STREET 2: 10 GLENLAKE PARKWAY NE, SUITE 700 CITY: ATLANTA STATE: 2Q ZIP: 30328 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AMERICOLD REALTY TRUST CENTRAL INDEX KEY: 0001455863 STANDARD INDUSTRIAL CLASSIFICATION: REAL ESTATE INVESTMENT TRUSTS [6798] IRS NUMBER: 000000000 STATE OF INCORPORATION: MD FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 10 Glenlake Pkwy., Suite 800 S. Tower CITY: Atlanta STATE: GA ZIP: 30328 BUSINESS PHONE: 678-441-1400 MAIL ADDRESS: STREET 1: 10 Glenlake Pkwy., Suite 800 S. Tower CITY: Atlanta STATE: GA ZIP: 30328 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-11-13 0 0001455863 AMERICOLD REALTY TRUST NYSE: COLD 0001229401 NOVOSEL THOMAS C C/O AMERICOLD REALTY TRUST 10 GLENLAKE PKWY, SOUTH TOWER, SUITE 600 ATLANTA GA 30328 0 1 0 0 See Remarks Common Shares of Beneficial Interest 2018-11-13 4 S 0 22726 26.00 D 0 D Common Shares of Beneficial Interest 2018-11-14 4 M 0 15000 9.81 A 15000 D Common Shares of Beneficial Interest 2018-11-14 4 S 0 15000 26.5297 D 0 D Stock Option 9.81 2018-11-14 4 M 0 15000 0.00 D 2023-10-30 Common Shares of Beneficial Interest 15000 0 D The price reported in Column 4 is a weighted average price. These common shares were sold in multiple transactions at prices ranging from $26.50 to $26.61, inclusive. The reporting person undertakes to provide to Americold Realty Trust, any security holder of Americold Realty Trust, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of common shares sold at each separate price within the range set forth above. On November 14, 2018, Mr. Novosel made an exercise of 15,000 stock options and sold 15,000 common shares of beneficial interest. Options to acquire common shares vested 20% on October 30, 2014, 2015, 2016, 2017 and 2018. Chief Accounting Officer and Senior Vice President /s/ Marc Smernoff, attorney-in-fact 2018-11-15